Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-27 Sale |
2020-08-31 4:42 pm |
Onconova Therapeutics Inc. | ONTX | Hoffman Michael B Director |
184,368 | $0.2719 | $50,130 | 22,483 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-12-20 6:58 pm |
N/A N/A |
Translational Development Acquisition Corp. | TDAC | TDAC Partners LLC Hoffman Michael B Das Avanindra 10% Owner |
0 | $0 | 4,657,500 (Direct) |
View |
Ownership |
2024-12-20 6:54 pm |
N/A N/A |
Translational Development Acquisition Corp. | TDAC | Hoffman Michael B Chief Executive Officer |
0 | $0 | 4,657,500 (Indirect) |
View |
| 2023-11-17 Option Award |
2024-07-03 5:16 pm |
N/A 2033-11-17 |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
29,600 | $0 | 29,600 (Direct) |
View |
| 2023-11-20 Option Award(A) |
2023-11-22 4:24 pm |
N/A N/A |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
163,880 | $6.1 | 1,639,640 (Indirect) |
View |
| 2023-11-20 Option Award |
2023-11-21 2:32 pm |
N/A N/A |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
164,745 | $6.07 | 1,640,505 (Indirect) |
View |
| 2023-04-07 Option Award |
2023-04-11 9:06 pm |
N/A N/A |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
59,477 | $12.61 | 1,475,760 (Indirect) |
View |
| 2023-01-18 Option Award |
2023-01-20 5:38 pm |
N/A 2033-01-18 |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
6,820 | $0 | 6,820 (Direct) |
View |
| 2022-01-04 Exercise |
2022-01-05 7:41 pm |
N/A N/A |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
7,142 | $0.25 | 1,425,283 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:41 pm |
N/A 2032-01-03 |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
9,000 | $0 | 1,425,283 (Direct) |
View |
| 2022-01-04 Exercise |
2022-01-05 7:41 pm |
N/A N/A |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
30,000 | $4.39 | 1,425,283 (Direct) |
View |
| 2022-01-04 Tax Withholding |
2022-01-05 7:41 pm |
N/A N/A |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
6,748 | $19.78 | 1,425,283 (Direct) |
View |
| 2022-01-04 Exercise |
2022-01-05 7:41 pm |
2020-07-01 2030-07-01 |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
37,142 | $0 | 1,425,283 (Direct) |
View |
| 2021-07-07 Option Award |
2021-07-09 6:26 pm |
N/A 2031-07-07 |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
4,500 | $0 | 4,500 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-10 5:29 pm |
2021-07-09 2030-07-09 |
Onconova Therapeutics Inc. | ONTX | Hoffman Michael B Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2020-07-01 Option Award(A) |
2020-07-06 4:30 pm |
2020-07-01 2030-07-01 |
Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner |
30,000 | $0 | 1,415,889 (Direct) |
View |